Real-Life Effectiveness and Safety of Baricitinib as Adjunctive to Standard-of-Care Treatment in Hospitalized Patients With Severe Coronavirus Disease 2019.
Tziolos N, Karofylakis E, Grigoropoulos I, Kazakou P, Koullias E, Savva A, Kranidioti H, Pelekanou A, Boulouta A, Pirounaki M, Tsiodras S, Georgiopoulos G, Boumpas DT, Kavatha D, Thomas K, Vassilopoulos D, Antoniadou A.
Tziolos N, et al. Among authors: tsiodras s.
Open Forum Infect Dis. 2021 Nov 22;9(1):ofab588. doi: 10.1093/ofid/ofab588. eCollection 2022 Jan.
Open Forum Infect Dis. 2021.
PMID: 34988257
Free PMC article.